These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 752872

  • 1. Value of adjuvant therapy with bacille Calmette Guerin (BCG) or dimethl triazeno imidazole carboximide (DTIC) in the control of minimal residual disease in stage II melanoma.
    Peter HH, Deutschmann KE, Deinhardt J, Deicher H.
    Recent Results Cancer Res; 1978; 68():367-74. PubMed ID: 752872
    [No Abstract] [Full Text] [Related]

  • 2. Adjuvant chemotherapy and immunotherapy in high risk patients with melanoma.
    El-Domeiri AA, Das Gupta TK, Trippon M, Simo C, Sabet TY, Crispen R.
    Surg Gynecol Obstet; 1978 Feb; 146(2):230-2. PubMed ID: 622668
    [Abstract] [Full Text] [Related]

  • 3. Randomized trial of adjuvant therapy for "high risk" primary malignant melanoma.
    Wood WC, Cosimi AB, Carey RW, Kaufman SD.
    Surgery; 1978 Jun; 83(6):677-81. PubMed ID: 644461
    [Abstract] [Full Text] [Related]

  • 4. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Gutterman JU, Mavligit GM, Reed R, Burgess MA, Gottlieb J, Hersh EM.
    Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
    [Abstract] [Full Text] [Related]

  • 5. Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin.
    Gutterman JU, Mavligit G, Gottlieb JA, Burgess MA, McBride CE, Einhorn L, Freireich EJ, Hersh EM.
    N Engl J Med; 1974 Sep 19; 291(12):592-7. PubMed ID: 4851001
    [No Abstract] [Full Text] [Related]

  • 6. Adjuvant therapy in malignant melanoma: a trial of immunotherapy. chemotherapy, and combined treatment.
    Kaufman SD, Cosimi AB, Wood WC, Carey RW.
    Recent Results Cancer Res; 1978 Sep 19; 68():380-6. PubMed ID: 752874
    [No Abstract] [Full Text] [Related]

  • 7. Controlled study for prolonged chemotherapy, immunotherapy, and chemotherapy plus immunotherapy as an adjuvant to surgery in malignant melanoma (Trial 6): preliminary report.
    Veronesi U, Beretta G.
    Recent Results Cancer Res; 1978 Sep 19; 68():375-9. PubMed ID: 752873
    [No Abstract] [Full Text] [Related]

  • 8. Effect of chemotherapy and immunotherapy on tumor-specific immunity in melanoma.
    Mitchell MS, Mokyr MB, Davis JM.
    J Clin Invest; 1977 Jun 19; 59(6):1017-26. PubMed ID: 863999
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Letter: Chemoimmunotherapy of malignant melanoma.
    N Engl J Med; 1975 Jan 16; 292(3):159-60. PubMed ID: 1196343
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chemoimmunotherapy for disseminated malignant melanoma: a prospective randomized study.
    Ramseur WL, Richards F, Muss HB, Rhyne L, Cooper MR, White DR, Stuart JJ, Spurr CL.
    Cancer Treat Rep; 1978 Jul 16; 62(7):1085-7. PubMed ID: 356970
    [Abstract] [Full Text] [Related]

  • 15. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.
    Agarwala SS, Neuberg D, Park Y, Kirkwood JM.
    Cancer; 2004 Apr 15; 100(8):1692-8. PubMed ID: 15073858
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chemoimmunotherapy for metastatic malignant melanoma using vincristine (NSC-67574), DTIC (NSC-45388) and Bacillus Calmette-Guerin.
    Thatcher N, Blackledge G, Palmer MK, Crowther D.
    Eur J Cancer (1965); 1981 Apr 15; 17(4):465-9. PubMed ID: 7308256
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Experience with adjuvant chemoimmunotherapy with DTIC and BCG in malignant melanoma (author's transl)].
    Pullmann H, Muth M.
    Z Hautkr; 1982 Feb 15; 57(4):294-7. PubMed ID: 7080583
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.